Development and validation of GCHSmethod used for trace level determination of carcinogenic Epichlorohydrin impurity in Rivaroxaban

  • Dr. Shaikh Tabrez Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India
  • Dr. Amit Gosar Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India
  • Neelam Mahadik Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India
  • Sanjay Pawar Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

Abstract

A simple, sensitive, and selective Headspace-Gas chromatography (GCHS) method was developed and validated for the trace level determination of Epichlorohydrin, which is a probable carcinogenic compound and may be present as a process impurity in Rivaroxaban drug substances. Identification and separation of analytes were achieved on a DB-Wax column having dimensions of 30 m in length and a 0.53 mm internal diameter with a 1.0 μm stationary film thickness. Nitrogen is used as a carrier gas with of flow rate of 6.0 mL/min. The run time of the method is 25 minutes. The gradient column oven-temperature programming method was used for analyte elution. The developed method was validated using ICH guidelines and found a linear in the range between 9.64 ppm and 80.31 ppm. The correlation coefficient and y-intercept observed for the linearity curve are 0.9993 and 1.75%, respectively. The limit of detection and quantitation were 3.03 ppm and 9.19 ppm, respectively. Recovery was observed for Epichlorohydrin between 94.66 % and 99.22 %. The RSD for system precision, precision at LOQ, and repeatability was less than 5.0 %. The developed method can be successfully applied to determine Epichlorohydrin in Rivaroxaban drug substances up to a very low trace level concentration. The method was found to be specific, selective, linear, precise, and accurate.


 

Keywords: Rivaroxaban, genotoxic, Epichlorohydrin, impurity, development, and validation

Downloads

Download data is not yet available.

Author Biographies

Dr. Shaikh Tabrez, Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

Dr. Amit Gosar, Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

Neelam Mahadik, Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

Sanjay Pawar, Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

Indoco Remedies Limited, Analytical research & development department, Navi Mumbai, 400701, Maharashtra, India

References

1. Halama A, Kruliš R, Rymeš J. A convenient synthesis of rivaroxaban from (S)-epichlorohydrin. Organic Preparations and Procedures International. 2020; 52(3):201-211.
2. Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V. Rivaroxaban: a new oral factor Xa inhibitor. Arteriosclerosis, thrombosis, and vascular biology. 2010; 30(3):376-381.
3. International Agency for Research on Cancer. Epichlorohydrin. IARC Summary & Evaluation, No. 71. http://www. inchem. org/documents/iarc/vol71/020-epichlorohydrin. html. 1999; 603.
4. Guideline, ICH Harmonized Tripartite. Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic RISK M7. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use (ICH): Geneva. 2014.
5. Snodin DJ, McCrossen SD. Guidelines and pharmacopoeial standards for pharmaceutical impurities: overview and critical assessment. Regulatory Toxicology and Pharmacology. 2012; 63(2):298-312.
6. Chan CC, Lee YC, Lam H, Zhang XM. Analytical method validation and instrument performance verification. John Wiley & Sons; 2004. p. 23.
7. Guideline ICH. Validation of analytical procedures: text and methodology Q2 (R1). International conference on harmonization, Geneva, Switzerland 2005 Nov (pp. 11-12).
Statistics
77 Views | 17 Downloads
How to Cite
Tabrez, D., Gosar, D., Mahadik, N., & Pawar, S. (2022). Development and validation of GCHSmethod used for trace level determination of carcinogenic Epichlorohydrin impurity in Rivaroxaban. Asian Journal of Pharmaceutical Research and Development, 10(3), 30-33. https://doi.org/https://doi.org/10.22270/ajprd.v10i3.1123